View of A Novel Bifunctional Hybrid Conjugate of 3-O-Methyl Ellagic Acid and Urolithin A via PEG₃ Linker: In Silico CDK2-Targeted Strategy for Lung Cancer Therapy

Return to Article Details A Novel Bifunctional Hybrid Conjugate of 3-O-Methyl Ellagic Acid and Urolithin A via PEG₃ Linker: In Silico CDK2-Targeted Strategy for Lung Cancer Therapy Download Download PDF